Weed (BUDZ) Current Assets (2010 - 2026)
Weed's (BUDZ) quarterly Current Assets came in at $12365.0 in Q1 2026, down 65.32% year-on-year from $35658.0 in Q1 2025, and down 74.08% quarter-over-quarter from $47705.0 in Q4 2025.
Weed (BUDZ) Current Assets (2010 - 2026) Analysis & Trends
Weed's Current Assets history runs 13 years deep, the most recent figure standing at $12365.0 for Q1 2026.
- On a quarterly basis, Current Assets fell 65.32% year-over-year to $12365.0 in Q1 2026; TTM through Mar 2026 was $12365.0, a 65.32% decrease from a year earlier, with the FY2025 full-year figure at $47705.0, down 74.88% from the prior year.
- Current Assets eased to $12365.0 in Q1 2026 per BUDZ's latest filing, from $47705.0 in the prior quarter.
- Across five years, Current Assets topped out at $922184.0 in Q2 2022 and bottomed at $10933.0 in Q3 2025.
- The 5-year median for Current Assets is $54968.0 (2023), against an average of $215215.4.
- Across the five-year window, Current Assets jumped 716.06% in 2022 and sank 94.24% in 2024, its largest moves.
- Year by year, Current Assets stood at $342075.0 in 2022, then decreased by 6.49% to $319886.0 in 2023, then sank by 40.64% to $189891.0 in 2024, then plunged by 74.88% to $47705.0 in 2025, then sank by 74.08% to $12365.0 in 2026.
- Per Business Quant, the three latest BUDZ Current Assets figures stand at $12365.0 (Q1 2026), $47705.0 (Q4 2025), and $10933.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Weed | 3.72 Mn | 3.72 Mn | - | 12,365.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12,365.00 |
| Dec 31, 2025 | 47,705.00 |
| Sep 30, 2025 | 10,933.00 |
| Jun 30, 2025 | 18,482.00 |
| Mar 31, 2025 | 35,658.00 |
| Dec 31, 2024 | 189,891.00 |
| Sep 30, 2024 | 39,381.00 |
| Jun 30, 2024 | 36,939.00 |
| Mar 31, 2024 | 128,570.00 |
| Dec 31, 2023 | 319,886.00 |
| Sep 30, 2023 | 684,123.00 |
| Jun 30, 2023 | 54,968.00 |
| Mar 31, 2023 | 119,459.00 |
| Dec 31, 2022 | 342,075.00 |
| Sep 30, 2022 | 643,393.00 |
| Jun 30, 2022 | 922,184.00 |
| Mar 31, 2022 | 52,650.00 |
| Dec 31, 2021 | 41,918.00 |
| Sep 30, 2021 | 338,090.00 |
| Jun 30, 2021 | 334,118.00 |